Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (112)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Brems, D. N.
Right arrow Articles by Frank, B. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brems, D. N.
Right arrow Articles by Frank, B. H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Protein Engineering vol. 5 no. 6 pp. 527-533, 1992
© 1992 Oxford University Press


RESEARCH-ARTICLE

Altering the association properties of insulin by amino acid replacement

David N. Brems, Leila A. Alter, Michael J. Beckage, Ronald E. Chance1, Richard D. DiMarchi1, L. Kenney Green1, Harlan B. Long1, Allen H. Pekar, James E. Shields1 and Bruce H. Frank

Parenteral Products Research and Development Indianapolis, IN 46285, USA 1Diabetes Research, Elt Lilly & Co. Indianapolis, IN 46285, USA

The importance of ProB28 and LysB29 on the self-association of insulin was established by systematically truncating the C terminus of the B chain. The relationship between structure and association was further explored by making numerous amino acid replacements at B28 and B29 Association was studied by circular dichroism, size-exclusion chromatography and ultracentrifugation. Our results show that the location of a prolyl residue at B28 is critical for high-affinity self-association. Removal of ProB28 in a series of C-terminal truncated insulins, or amino acid replacement of Pro28, greatly reduced association. The largest disruption to association was achieved by replacing LysB29 with Pro and varying the amino acid at B28 Several of the analogs were predominantly monomers in solutions up to 3 mg/ml. These amino acid substitutions decreased association by primarily disrupting the formation of dimers. Such amino acid substitutions also substantially reduced the Zn-induced insulin hexamer formation. The formation of monomeric insulins through amino acid replacements was accompanied by conformational changes that may be the cause for decreased association. It is demonstrated that self-association of insulin can be drastically altered by substitution of one or two key amino acids.

Keywords: circular dichroism/mutagenesis/self-association/size-exclusion/ultracentrifugation

Received March 12, 1992; revised May 22, 1992; accepted June 17, 1992.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Q.-x. Hua, B. Xu, K. Huang, S.-Q. Hu, S. Nakagawa, W. Jia, S. Wang, J. Whittaker, P. G. Katsoyannis, and M. A. Weiss
Enhancing the Activity of a Protein by Stereospecific Unfolding: CONFORMATIONAL LIFE CYCLE OF INSULIN AND ITS EVOLUTIONARY ORIGINS
J. Biol. Chem., May 22, 2009; 284(21): 14586 - 14596.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q.-x. Hua, S. H. Nakagawa, W. Jia, K. Huang, N. B. Phillips, S.-q. Hu, and M. A. Weiss
Design of an Active Ultrastable Single-chain Insulin Analog: SYNTHESIS, STRUCTURE, AND THERAPEUTIC IMPLICATIONS
J. Biol. Chem., May 23, 2008; 283(21): 14703 - 14716.
[Abstract] [Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
B. Ahmad
Review: Pharmacology of insulin
The British Journal of Diabetes & Vascular Disease, January 1, 2004; 4(1): 10 - 14.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Weiss, Q.-X. Hua, W. Jia, S. H. Nakagawa, Y.-C. Chu, S.-Q. Hu, and P. G. Katsoyannis
Activities of Monomeric Insulin Analogs at Position A8 Are Uncorrelated with Their Thermodynamic Stabilities
J. Biol. Chem., October 19, 2001; 276(43): 40018 - 40024.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
H. Chen, M. Shi, Z.-Y. Guo, Y.-H. Tang, Z.-S. Qiao, Z.-H. Liang, and Y.-M. Feng
Four new monomeric insulins obtained by alanine scanning the dimer-forming surface of the insulin molecule
Protein Eng. Des. Sel., November 1, 2000; 13(11): 779 - 782.
[Abstract] [Full Text] [PDF]


Home page
The Diabetes EducatorHome page
J. Ung, M. Hu, T. Hagerup, and R. K. Campbell
Lispro Insulin: Adsorption and Stability in Selected Intravenous Devices
The Diabetes Educator, March 1, 1999; 25(2): 237 - 245.
[Abstract] [PDF]


Home page
International Journal of ToxicologyHome page
J. L. Zimmermann and L. L. Truex
12-Month Chronic Toxicity Study of LY275585 (Human Insulin Analog) Administered Subcutaneously to Fischer 344 Rats
International Journal of Toxicology, November 1, 1997; 16(6): 639 - 657.
[Abstract] [PDF]


Home page
NEJMHome page
F. Holleman and J. B.L. Hoekstra
Insulin Lispro
N. Engl. J. Med., July 17, 1997; 337(3): 176 - 183.
[Full Text] [PDF]


Home page
International Journal of ToxicologyHome page
J. Buelke-Sam, R. A. Byrd, J. A. Hoyt, and J. L. Zimmermann
A Reproductive and Developmental Toxicity Study in CD Rats of LY275585, [Lys(B28),Pro(B29)]-Human Insulin
International Journal of Toxicology, August 1, 1994; 13(4): 247 - 260.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.